Incomplete Freund's adjuvant reduces arginase and enhances Th1 dominance, TLR signaling and CD40 ligand expression in the vaccine site microenvironment.
Karlyn E PollackMax O MeneveauMarit M MelssenKevin T LynchAlexander F KoeppelSamuel J YoungStephen TurnerPankaj KumarKatia Sol-ChurchIleana S MauldinCraig L SlingluffPublished in: Journal for immunotherapy of cancer (2021)
(NCT00705640, NCT01585350).